Results 81 to 90 of about 107,439 (309)

Poisoning with the recreational drug paramethoxyamphetamine ("death") [PDF]

open access: yes, 2001
The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.Objective: To describe the clinical features of paramethoxyamphetamine (PMA; "death ...
Buckley, N.   +4 more
core   +1 more source

A cost–benefit analysis of the implementation and scale‐up of harm reduction interventions in the Australian Capital Territory

open access: yesAddiction, EarlyView.
Abstract Background and aims Harm reduction interventions aim to reduce negative consequences of drug use. We aimed to estimate the cost, health impact and economic benefits of current, expanded and new harm reduction interventions for people who use drugs in the Australian Capital Territory.
Anna L. Bowring   +8 more
wiley   +1 more source

Chemical Profile of Ecstasy Tablets – a Review

open access: yesBrazilian Journal of Forensic Sciences, Medical Law and Bioethics, 2013
Ecstasy is a popular name of a substance called 3,4-methylenedioxymethamphetamine (MDMA). Pharmacologically it displays effects related to amphetamine-type drugs like restlessness, well-being, and others.
Emanuele Amorim Alves   +1 more
doaj  

A meta‐analysis of sexual orientation inequities in substance use among youth

open access: yesAddiction, EarlyView.
Abstract Background and Aims Sexual minority youth report significantly higher rates of substance use than heterosexual youth, yet a comprehensive and systematic evaluation and synthesis of the magnitude of this inequity has not been conducted. The purpose of this study was to conduct a meta‐analysis to assess the magnitude of overall inequities in ...
Ethan H. Mereish   +4 more
wiley   +1 more source

MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent 'Ecstasy' users. [PDF]

open access: yes, 2017
MDMA/Ecstasy has had a resurgence in popularity, with recent supplies comprising higher strength MDMA, potentially leading to increased drug-related harm.
Andrew C. Parrott   +67 more
core   +2 more sources

Hippocampal subfield differences in people with and without recreational ketamine use: Insights from multi‐modal neuroimaging

open access: yesAddiction, EarlyView.
Abstract Background and aims Recreational ketamine use has increased globally and is associated with psychiatric and cognitive concerns. The hippocampus in preclinical models shows damage and working‐memory disruption with repeated dosing. However, whether specific hippocampal subregions may differ in people with chronic ketamine use remains unclear ...
Yi‐Hsuan Liu   +8 more
wiley   +1 more source

Ecstasy Use Among High School Students in Lahidjan- 2005

open access: yesمجله اپیدمیولوژی ایران, 2006
Background & Objectives: Ecstasy is a methamphetamine derivative becoming increasingly popular throughout the world, particularly among adolescents and young adults.
Z Mohtasham Amiri   +2 more
doaj  

Diabetic ketoacidosis complicated by the use of ecstasy: a case report

open access: yesJournal of Medical Case Reports, 2010
Introduction Ecstasy (3,4-methylenedioxymethamphetamin), a hallucinogenic amphetamine, is often used by young people, especially at 'raves'. This illicit drug can cause many metabolic changes and its use, when associated with prolonged exercise, may ...
Ossowski Ana   +3 more
doaj   +1 more source

The nature of ecstasy-group related deficits in associative learning [PDF]

open access: yes
Rationale/objectives: Research has revealed associative learning deficits among users of ecstasy; the present study explored the component processes underlying these deficits.
Fisk, JE, Montgomery, C, Newcombe, R
core   +1 more source

Home - About - Disclaimer - Privacy